These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18284623)

  • 21. Autopsy diagnosis of progressive multifocal leukoencephalopathy with JC virus-negative CSF after cord blood stem-cell transplantation.
    Sheikh SI; Stemmer-Rachamimov A; Attar EC
    J Clin Oncol; 2009 Aug; 27(23):e46-7. PubMed ID: 19451419
    [No Abstract]   [Full Text] [Related]  

  • 22. Alternative donor transplants for high-risk acute myeloid leukemia.
    Gupta V
    Curr Opin Hematol; 2008 Mar; 15(2):115-20. PubMed ID: 18300757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification.
    Michel G; Cunha R; Ruggeri A; O'Brien TA; Bittencourt H; Dalle JH; Locatelli F; Iori AP; Mauad M; Oudin C; Giannotti F; Volt F; Gluckman E; Bader P; Rocha V
    Leukemia; 2016 May; 30(5):1180-3. PubMed ID: 26369981
    [No Abstract]   [Full Text] [Related]  

  • 24. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
    J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thyrotoxicosis after cord blood transplantation for acute myelogenous leukemia].
    Motohashi K; Sakai R; Hagihara M; Enaka M; Kanamori H; Maruta A; Ishigatsubo Y
    Rinsho Ketsueki; 2008 Dec; 49(12):1631-3. PubMed ID: 19110527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual physician practice variation in hematopoietic cell transplantation.
    Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
    J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
    Petersen FB; Ford CD
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S7-9. PubMed ID: 19561415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosome 8 pentasomy with partial tandem duplication of 11q23 in a case of de novo acute myeloid leukemia.
    Shin SY; Koo SH; Kwon KC; Park JW; Song JH; Ko YH; Jo DY
    Cancer Genet Cytogenet; 2009 Oct; 194(1):44-7. PubMed ID: 19737653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
    Ferrara F; Mele G; Palmieri S; Pedata M; Copia C; Riccardi C; Izzo T; Criscuolo C; Musto P
    Hematol Oncol; 2009 Dec; 27(4):198-202. PubMed ID: 19475701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Lekakis L; de Lima M
    Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
    Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Kasahara S; Uchimaru K; Iseki T; Tojo A; Asano S
    Leuk Res; 2009 Jun; 33(6):840-2. PubMed ID: 18995897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
    Saito M; Mori A; Irie T; Tanaka M; Morioka M
    Rinsho Ketsueki; 2009 Mar; 50(3):192-6. PubMed ID: 19352087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated tuberculosis following second unrelated cord blood transplantation for acute myelogenous leukemia.
    Shima T; Yoshimoto G; Miyamoto T; Yoshida S; Kamezaki K; Takenaka K; Iwasaki H; Harada N; Nagafuji K; Teshima T; Shimono N; Akashi K
    Transpl Infect Dis; 2009 Feb; 11(1):75-7. PubMed ID: 19000153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lineage switch of acute lymphocyctic leukaemia with t(4;11)(q21;q23) into acute myeloid leukaemia in an adult patient after allogeneic stem cell transplantation.
    Trikalinos NA; Soupir CP; Dey BR
    Br J Haematol; 2009 Apr; 145(2):262-4. PubMed ID: 19208102
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.
    Ferrara F; Palmieri S; Pedata M; Viola A; Izzo T; Criscuolo C; Mele G
    Hematol Oncol; 2009 Mar; 27(1):40-5. PubMed ID: 19206083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
    Bacher U; Klyuchnikov E; Zabelina T; Ottinger H; Beelen DW; Schrezenmeier H; Ehninger G; Müller C; Berger J; Suttorp M; Kolb HJ; Kröger N; Zander AR
    Ann Hematol; 2009 Dec; 88(12):1237-47. PubMed ID: 19319532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.